Anti-amyloid beta monoclonal antibody therapies (anti-A mAbs) for early-stage Alzheimer s disease (AD) represent a welcome development as the first disease-modifying treatments in the space. However, with their variety of class-specific considerations, their integration into practice can require significant workflow modifications and heightened interdisciplinary coordination. To assist practicing clinicians in designing and/or enhancing care delivery platforms related to the use of anti-A mAbs, this three-part series features a panel of neurology and radiology specialists walking through examples of how they leverage their electronic health records (EHR) and other related protocols to streamline the identification and management of patients eligible for these therapies. This third activity focuses on the detection of amyloid-related imaging abnormalities (ARIA) and adverse event management in patients prescribed anti-A mAb therapy.
Credit & MOC Details
Credit information is provided by the course provider. We recommend confirming credit eligibility with the provider or your licensing board before starting the activity.
Credit types
MOC types
FDA REMS
Qualifies for MIPS
Target Specialties
Pricing
All courses included · from $18.75/mo
Courses are included in the subscription; some are also sold individually.
| Student Flex | $18.75/mo |
| Professional Flex | $60/mo |
| Student 3-Year | $100 |
| Student 2-Year | $112.50 |
+4 more plans
Collected from the provider’s public pages · source
Specialties served/covered
- Cardiovascular Disease
- Communication & Shared Decision-Making
- Dermatology
- Endocrinology, Diabetes & Metabolism
- Family Medicine
- Gastroenterology
- Gastrointestinal Surgery
- General & Adult Psychiatry
- General Internal Medicine
- Gynecologic Oncology
- Health Equity & Inclusion
- Hematology
- Maternal-Fetal Medicine
- Medical Leadership & Administration
- Medical Oncology
- Mood & Anxiety Disorders
- Nephrology
- Neurocritical Care
- Neurodevelopmental Disabilities
- Neurology
- Neuroradiology
- Nuclear Medicine
- Obstetrics & Gynecology
- Ophthalmology
- Plastic & Reconstructive Surgery
- Practice Management & Ethics
- Pulmonary Disease
- Sleep Medicine
- Surgical Oncology
- Thoracic Anesthesia
- Urological Oncology
- Anesthesiology
- Cardio-Vascular
- Cross-Specialty
- Emergency & Critical Care
- GI & Liver
- Infectious Disease
- Internal Medicine
- Medical Subspecialties
- Neurology
- Ob/Gyn
- Oncology & Hematology
- Primary care
- Psychiatry
- Radiology
- Surgery
- Urology
- No reviews yet. Be the first to share yours.
Pricing
Free
Reported to ACCME by the provider
- Conference / congress
- Credit · Up to 1 credit
- Commercial Support
-
ReleasedOct 27, 2025
-
Last day to claim creditOct 28, 2026 2 weeks left
-
Efficient, LLC +1 The First Dose and Beyond: Follow-Up and Management with Anti-Amyloid Beta Monoclonal Antibody Therapy
-
Plexus Communications +1 Contemporary B-ALL Care: Practical Integration and Use of CD19-Directed Bispecific Antibodies
-
Plexus Communications +1 Bringing BTK Inhibitors to the Frontline Setting: Essential Advancements in Mantle Cell Lymphoma Management
